Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Longevitytech.fund
AddedFeb 13, 2024
UpdatedJun 28, 2026
Longevitytech.fund

Longevitytech.fund

Operating

Florida-based Longevitytech.fund invests in early-stage startups in aging research, biotech, and AI, offering entrepreneurial and commercialization support.

Location
Boca Raton, FL, US
Founded
2020
Firm
Compare
Portfolio
Employees
Website

Investments

Rejuvenation Technologies Inc.
Rejuvenation Technologies Inc.

Total Raised

$15.3M

Rounds

9

Seed$10.6MSeptember 2023
DebtDecember 2021
SiPhox Health
SiPhox Health

Total Raised

$32.8M

Rounds

4

Seed$10MJuly 2023
Convertible NoteDecember 2021
Remedium Bio
Remedium Bio

Total Raised

$2.3M

Rounds

3

Seed$2.3MAugust 2022
Sampling Human
Sampling Human

Total Raised

$3.7M

Rounds

3

Seed$2MApril 2022
Convertible NoteDecember 2021
Celeris Therapeutics
Celeris Therapeutics

Total Raised

$16.5M

Rounds

5

Seed$3MFebruary 2022
Pre-Seed$400kMarch 2021
BrainKey
BrainKey
Debt

Total Raised

$350k

Rounds

3

DebtDecember 2021
Petri Bio
Petri Bio

Total Raised

$255k

Rounds

1

Seed$255kOctober 2021
Juvena Therapeutics
Juvena Therapeutics

Total Raised

$49.2M

Rounds

6

—October 2021
Novos
Novos

Total Raised

$3.1M

Rounds

3

Pre-Seed$3.1MOctober 2021
Maxwell Biosciences
Maxwell Biosciences

Total Raised

$10.8M

Rounds

4

SeedOctober 2021
Samsara Therapeutics
Samsara Therapeutics

Total Raised

$13.5M

Rounds

5

Series A$10.3MJuly 2021
Repair Biotechnologies
Repair Biotechnologies

Total Raised

$11M

Rounds

5

SeedSeptember 2020
Life Biosciences
Life Biosciences

Total Raised

$206.8M

Rounds

4

Series Unknown$74.8MMay 2020
Animal Biosciences
Animal Biosciences

Total Raised

$2.3M

Rounds

3

SeedMay 2020
Gerostate Alpha
Gerostate Alpha

Total Raised

$150k

Rounds

2

SeedApril 2019